Krystal Biotech

KRYS · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reported earnings about 1 month ago

Total Revenue

$107M

Previous year: $91.1M

VYJUVEK Net Product Revenue

$107M

Previous year: $91.1M

+17.5%

VYJUVEK Gross Margin

94%

VYJUVEK Reimbursement Approvals

Previous year: $1.06B

+26.3%

Loading...

Krystal Biotech

Unlock previous datapoints

Upgrade

Krystal Biotech

Unlock previous datapoints

Upgrade

Krystal Biotech Revenue by Segment

Krystal Biotech Revenue by Geographic Location

Revenue by Segment

VYJUVEK Net Product Revenue

CapyFin.com

Revenue by Geographic Location

United States Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$7.22B

P/E Ratio

35.19

Sector

N/A

Industry

N/A

52-Week High

$292

52-Week Low

$123

VYJUVEK Net Product Revenue

$107M

VYJUVEK Gross Margin

94%

VYJUVEK Reimbursement Approvals

660

R&D Expenses

$14.8M

SG&A Expenses

$41.4M

Products

Get in Touch

Resources

Krystal Biotech

Krystal Biotech

Krystal Biotech

Krystal Biotech Revenue by Segment

Krystal Biotech Revenue by Geographic Location

Revenue by Segment

VYJUVEK Net Product Revenue

Revenue by Geographic Location

United States Revenue

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics